Presented at the 2022 Michigan Society of Professional Engineers (MSPE) annual conference, ROWE CEO Leanne Panduren, PE, FNSPE, FMSPE, was honored with the Diamond Award. New for MSPE’s 75th anniversary, the Diamond Award recognizes members who have provided exemplary service to the Society, including leadership at the state level, fostering membership, protecting the practice, securing the future and providing a hand in governance.
Allisyn Mattice-Eskau, director of government & regulatory affairs for McLaren Health Care, whose accomplishments and strong dedication to health care advancement through legislation, landed her a spot on the list of “30 in Their Thirties 2022,” an annual compilation of business professionals in their 30s who have achieved notable success produced by DBusiness Magazine.
“The McLaren system covers a substantial portion of the state, serving a diverse patient population, who have an array of needs from their health care but may face certain barriers,” said Mattice-Eskau, who joined McLaren in March 2020. “It’s been very rewarding to see how impactful our legislative achievements can be to a patient, and that’s a task I enjoy working toward.”
The Karmanos Cancer Institute at McLaren Flint welcomed fellowship-trained and board-certified gynecologic oncologist Dr. Benjamin Mize, MD to the cancer care team. Dr. Mize joins Dr. John J. Wallbillich, MD, in Flint to provide advanced care to women who are diagnosed with cancers within or near the female reproductive system.
“I am thrilled to be joining the team in Flint to further provide exceptional cancer care to women in Genesee County,” Dr. Mize said. “I will work closely with my colleague, Dr. Wallbillich, along with the multidisciplinary team in Detroit, and the medical, surgical, and radiation oncology teams right here in Flint to provide comprehensive cancer care and treatment plans for our patients’ success.”
Dr. Mize has training in obstetrics and gynecologic oncology, with specializations in surgical oncology and medical management of gynecologic cancers where indicated.
Ascension Genesys Hospital received an “A” grade in the Spring 2022 Leapfrog Hospital Safety Grade, a national distinction recognizing the hospital’s achievements in protecting patients from preventable harm and error in the hospital. The Leapfrog Group is an independent national watchdog organization committed to healthcare quality and safety. The Leapfrog Hospital Safety Grade assigns an “A,” “B,” “C,” “D,” or “F” grade to all general hospitals across the country and is updated every six months.
“I am so proud of the hard work that continues to be done at Ascension Genesys Hospital to focus on the safety of our patients,” said Christopher Palazzolo, president of Ascension Genesys. “Our patient safety efforts make a difference in the quality care we provide, and in the lives of all of those who entrust us with their care.”
“I thank the workforce and leadership of Ascension Genesys Hospital for their sustained commitment to patient safety, day in and day out,” said Leah Binder, president and CEO of The Leapfrog Group. “An ‘A’ Safety Grade is an outstanding achievement, and one that is not possible without a 24/7 effort by the entire healthcare workforce to protect patients from harm. This community should be proud.”